DEAD-Box Helicase 27 Triggers Epithelial to Mesenchymal Transition by Regulating Alternative Splicing of Lipoma-Preferred Partner in Gastric Cancer Metastasis

DEAD-box helicase 27 (DDX27) was previously identified as an important mediator during carcinogenesis, while its role in gastric cancer (GC) is not yet fully elucidated. Here, we aimed to investigate the mechanism and clinical significance of DDX27 in GC. Public datasets were analyzed to determine D...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in genetics Vol. 13; p. 836199
Main Authors Jin, Yirong, Yang, Suzhen, Gao, Xiaoliang, Chen, Di, Luo, Tingting, Su, Song, Shi, Yanting, Yang, Gang, Dong, Lei, Liang, Jie
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 04.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:DEAD-box helicase 27 (DDX27) was previously identified as an important mediator during carcinogenesis, while its role in gastric cancer (GC) is not yet fully elucidated. Here, we aimed to investigate the mechanism and clinical significance of DDX27 in GC. Public datasets were analyzed to determine DDX27 expression profiling. The qRT-PCR, Western blot, and immunohistochemistry analyses were employed to investigate the DDX27 expression in GC cell lines and clinical samples. The role of DDX27 in GC metastasis was explored and . Mass spectrometry, RNA-seq, and alternative splicing analysis were conducted to demonstrate the DDX27-mediated molecular mechanisms in GC. We discovered that DDX27 was highly expressed in GCs, and a high level of DDX27 indicated poor prognosis. An increased DDX27 expression could promote GC metastasis, while DDX27 knockdown impaired GC aggressiveness. Mechanically, the LLP expression was significantly altered after DDX27 downregulation, and further results indicated that LPP may be regulated by DDX27 alternative splicing. In summary, our study indicated that DDX27 contributed to GC malignant progression a prometastatic DDX27/LPP/EMT regulatory axis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Yaseswini Neelamraju, University of Virginia, United States
Reviewed by: Massimo Zollo, University of Naples Federico II, Italy
These authors have contributed equally to this work
This article was submitted to Cancer Genetics and Oncogenomics, a section of the journal Frontiers in Genetics
Edited by: Jitian Li, Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital), China
ISSN:1664-8021
1664-8021
DOI:10.3389/fgene.2022.836199